GILUPI Nanomedizin - Product Pipeline Analysis, 2014 Update

Date: August 6, 2014
Pages: 20
Price:
US$ 750.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: E7D5137D8D7EN
Leaflet:

Download PDF Leaflet

GILUPI Nanomedizin - Product Pipeline Analysis, 2014 Update
Summary

GILUPI Nanomedizin (GILUPI) develops and commercializes medical devices for isolating rare cells from blood for diagnosis. It develops a new medical detector which is used in-vivo in a patient’s vein for catching rare cells such as tumor cells or fetal cells. GILUPI’s products are used in the therapeutic areas of diagnosing lung cancer, breast cancer, prostate cancer and prenatal diagnosis. The company has developed CellCollector for the in vivo isolation of circulating tumor cells. It has its presence in Berlin, Hamburg, Cologne, Frankfurt and Munich. The company partners with Bayer Pharma AG, University Hospital Halle, Greater Poland Cancer Centre, and University Medical Center Ulm, among others. GILUPI is headquartered in Potsdam, Germany.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company GILUPI Nanomedizin
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
GILUPI Nanomedizin Company Snapshot
GILUPI Nanomedizin Company Overview
Key Information
GILUPI Nanomedizin Pipeline Products and Clinical Trials Overview
GILUPI Nanomedizin – Pipeline Analysis Overview
Key Facts
GILUPI Nanomedizin - Major Products and Services
GILUPI Nanomedizin Pipeline Products by Development Stage
GILUPI Nanomedizin Pipeline Products Overview
CellCollector Device - Cardiovascular Disease
CellCollector Device - Cardiovascular Disease Product Overview
CellCollector Device - Sepsis
CellCollector Device - Sepsis Product Overview
Diagnostic Test - Breast Cancer
Diagnostic Test - Breast Cancer Product Overview
Diagnostic Test - Down's Syndrome
Diagnostic Test - Down's Syndrome Product Overview
Diagnostic Test - Lung Cancer
Diagnostic Test - Lung Cancer Product Overview
Diagnostic Test - Prostate Cancer
Diagnostic Test - Prostate Cancer Product Overview
GILUPI Nanomedizin - Key Competitors
GILUPI Nanomedizin - Key Employees
GILUPI Nanomedizin - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

GILUPI Nanomedizin, Key Facts
GILUPI Nanomedizin Pipeline Products and Clinical Trials Overview
GILUPI Nanomedizin Pipeline Products by Equipment Type
GILUPI Nanomedizin Pipeline Products by Indication
GILUPI Nanomedizin, Key Facts
GILUPI Nanomedizin, Major Products and Services
GILUPI Nanomedizin Number of Pipeline Products by Development Stage
GILUPI Nanomedizin Pipeline Products Summary by Development Stage
CellCollector Device - Cardiovascular Disease - Product Status
CellCollector Device - Cardiovascular Disease - Product Description
CellCollector Device - Sepsis - Product Status
CellCollector Device - Sepsis - Product Description
Diagnostic Test - Breast Cancer - Product Status
Diagnostic Test - Breast Cancer - Product Description
Diagnostic Test - Down's Syndrome - Product Status
Diagnostic Test - Down's Syndrome - Product Description
Diagnostic Test - Lung Cancer - Product Status
Diagnostic Test - Lung Cancer - Product Description
Diagnostic Test - Prostate Cancer - Product Status
Diagnostic Test - Prostate Cancer - Product Description
GILUPI Nanomedizin, Key Employees
GILUPI Nanomedizin, Other Locations

LIST OF FIGURES

GILUPI Nanomedizin Pipeline Products by Equipment Type
GILUPI Nanomedizin Pipeline Products by Development Stage
Claros Diagnostics, Inc. - Product Pipeline Analysis US$ 750.00 Oct, 2011 · 25 pages
Focus Diagnostics, Inc. - Product Pipeline Analysis US$ 750.00 Nov, 2012 · 20 pages
Corgenix, Inc. - Product Pipeline Analysis US$ 750.00 Oct, 2011 · 17 pages
IR Diagnostyx Inc. - Product Pipeline Analysis US$ 750.00 Jun, 2012 · 20 pages
AutoGenomics, Inc. - Product Pipeline Analysis US$ 750.00 Jun, 2012 · 24 pages

Ask Your Question

GILUPI Nanomedizin - Product Pipeline Analysis, 2014 Update
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: